Interaction of vascular smooth muscle cells and monocytes by soluble factors synergistically enhances IL-6 and MCP-1 production
Authors:
- Adrian FristerAFAdrian Frister
- Song WangSWSong Wang
- Andreas LudwigALAndreas Ludwig
- Hagen BehrHBHagen Behr
- Susanna PippigSPSusanna Pippig
- Beibei LiBLBeibei Li
- Andreas SimmASAndreas Simm
- Britt HofmannBHBritt Hofmann
- Claudia PilowskiCPClaudia Pilowski
- Susanne KochSKSusanne Koch
- Michael BuerkeMBMichael Buerke
- 1 April 2009
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 296 (4) , H987-H996
Abstract
Inflammatory mechanisms contribute to atherogenesis. Monocyte chemoattractant protein (MCP)-1 and IL-6 are potent mediators of inflammation. Both contribute to early atherogenesis by luring monocytes and regulating cell functions in the vessel wall. MCP-1 and IL-6 production resulting from the interaction of invading monocytes with local vessel wall cells may accelerate atherosclerosis. We investigated the influence of the interaction of human vascular smooth muscle cells (SMCs) with human mononuclear cells (MNCs) or monocytes on IL-6 and MCP-1 production in a coculture model. Interaction synergistically enhanced IL-6 and MCP-1 production (up to 30- and 10-fold, respectively) compared with separately cultured cells. This enhancement was mediated by CD14-positive monocytes. It was dependent on the SMC-to-MNC/monocyte ratio, and as few as 0.2 monocytes/SMC induced the synergism. Synergistic IL-6 production was observed at the protein, mRNA, and functional level. It was mediated by soluble factors, and simultaneous inhibition of IL-1, TNF-α, and IL-6 completely blocked the synergism. IL-1, TNF-α, and IL-6 were present in the cultures. Blockade of the synergism by soluble glycoprotein 130Fc/soluble IL-6 receptor, as well as the induction of synergistic IL-6 production by costimulation of SMCs with IL-1, TNF-α, and hyper-IL-6, suggested the involvement of IL-6 trans-signaling. The contribution of IL-6 was consistent with enhanced STAT3 phosphorylation. The present data suggest that SMC/monocyte interactions may augment the proinflammatory status in the tissue, contributing to the acceleration of early atherogenesis.Keywords
This publication has 46 references indexed in Scilit:
- Cytokines and atherosclerosis: a comprehensive review of studies in miceCardiovascular Research, 2008
- Atheroprotective role of interleukin-6 in diet- and/or pathogen-associated atherosclerosis using an ApoE heterozygote murine modelAtherosclerosis, 2008
- Cardiotrophin-1 stimulates intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human aortic endothelial cellsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Endotoxin-activated cultured neonatal rat cardiomyocytes express functional surface-associated interleukin-1αInnate Immunity, 2007
- Endogenous VEGF-A is responsible for mitogenic effects of MCP-1 on vascular smooth muscle cellsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Endotoxin and Tumor Necrosis FactorαExert a Similar Proinflammatory Effect in Neonatal Rat Cardiomyocytes, but have Different Cardiodepressant Profiles,Journal of Molecular and Cellular Cardiology, 1998
- Human Vascular Smooth Muscle Cells Express Interleukin-1β–converting Enzyme (ICE), but Inhibit Processing of the Interleukin-1β Precursor by ICEJournal of Experimental Medicine, 1997
- Role of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte RecruitmentImmunity, 1997
- Differential shedding of the two subunits of the interleukin‐6 receptorFEBS Letters, 1993
- Adult human vascular endothelial cells express the IL6 gene differentially in response to LPS or IL1Cellular Immunology, 1989